Boston’s Raphy Gil and Cleveland’s Abrahan Tejada, both 19-year-old pitchers competing in the Dominican Summer League, received 56-game suspensions from Major League Baseball on Thursday due to positive tests for the banned performance-enhancer stanozolol.

These sanctions were handed down as part of MLB’s drug enforcement program for minor league athletes not participating within the United States and Canada.

Gil, who joined the Boston organization in June, showcased impressive skills with a remarkable 0.90 ERA over eight appearances this season. Meanwhile, Tejada signed on with Cleveland in 2022, commanding a $45,000 signing bonus. He has recorded a 2-0 record with a 5.28 ERA through 12 relief outings this year, although he did not participate in the 2023 season due to UCL surgery on his right elbow.

This year has seen a total of seventeen players banned following positive drug tests. Of those, nine falls under the new initiative for minor league players stationed outside the U.S. and Canada, while six have been suspended under the traditional minor league program.

In addition to these cases, two athletes have faced disciplinary action under the major league drug policy. Cincinnati Reds’ top prospect, 22-year-old infielder Noelvi Marté, endured an 80-game suspension after testing positive for boldenone. Similarly, Orelvis Martínez, an infielder for the Toronto Blue Jays, received an 80-game suspension on June 23 for testing positive for clomiphene, which was revealed shortly after his major league debut.